develop
countri
face
uniqu
diffi
culti
prepar
infl
uenza
pandem
current
topdown
approach
provid
countri
adequ
suppli
vaccin
antivir
agent
consequ
use
bottomup
approach
base
inexpens
gener
agent
either
modifi
host
respons
infl
uenza
viru
act
antivir
agent
sever
agent
shown
promis
mani
current
produc
develop
countri
investig
must
primarili
identifi
agent
manag
infect
popul
simpli
seek
explan
work
must
determin
countri
agent
produc
defi
ne
pattern
distribut
cost
prepandem
research
establish
whether
agent
effect
pandem
random
control
trial
must
begin
immedi
new
pandem
viru
emerg
without
research
industri
develop
countri
could
face
unpreced
health
crisi
ore
decad
ago
fi
rst
human
case
diseas
caus
avian
infl
uenza
viru
appear
hong
kong
special
administr
region
peopl
republ
china
six
year
ago
infl
uenza
viru
reemerg
caus
highli
lethal
human
diseas
southeast
asia
health
offi
cial
concern
case
could
harbing
next
infl
uenza
pandem
result
virtual
industri
countri
mani
develop
countri
mount
extens
pandem
prepared
effort
howev
point
recent
oshitani
et
al
industri
countri
face
uniqu
diffi
cult
issu
make
prepar
pandem
challeng
pandem
form
infl
uenza
viru
emerg
within
next
year
countri
depend
almost
entir
eggderiv
inactiv
adjuv
infl
uenza
vaccin
develop
countri
approach
succeed
estim
show
within
fi
rst
month
pandem
outbreak
vaccin
compani
abl
produc
enough
dose
vaccin
million
person
number
less
combin
popul
countri
produc
almost
world
season
infl
uenza
vaccin
countri
fi
rst
use
vaccin
ensur
popul
protect
nonvaccineproduc
countri
industri
develop
wait
repres
world
health
organ
global
programm
infl
uenza
conclud
develop
countri
access
vaccin
fi
rst
wave
pandem
perhap
throughout
durat
sinc
work
build
stockpil
million
dose
vaccin
infl
uenza
viru
develop
countri
compani
pledg
provid
million
dose
scientifi
c
consult
use
stockpil
conclud
suffi
cient
earli
warn
outbreak
infl
uenza
due
viru
capabl
sustain
humantohuman
transmiss
theoret
may
rel
limit
window
opportun
stop
spread
viru
spread
nation
intern
howev
contain
effort
would
feasibl
set
number
local
case
sic
still
limit
adequ
logist
support
avail
nation
govern
support
intern
assist
vaccin
stockpil
effort
would
depend
yet
exist
sever
industri
countri
stockpil
vaccin
infl
uenza
viru
might
use
prepandem
vaccin
oshitani
et
al
note
pandem
prepandem
vaccin
would
avail
develop
countri
unless
intern
mechan
exist
share
vaccin
low
cost
even
limit
suppli
vaccin
could
produc
develop
countri
intern
mechan
place
pay
distribut
vaccin
yet
announc
plan
set
one
thu
next
pandem
viru
emerg
almost
vaccin
avail
develop
countri
slow
spread
global
suppli
vaccin
pandem
virus
limit
govern
offi
cial
industri
countri
place
hope
stockpil
antivir
agent
primarili
oseltamivir
expens
neuraminidas
inhibitor
establish
southeast
asian
infl
uenza
clinic
research
network
studi
neuraminidas
inhibitor
treatment
patient
infect
virus
possess
pandem
potenti
howev
infl
uenza
viru
develop
resist
oseltamivir
similar
antivir
resist
could
develop
futur
pandem
viru
five
million
treatment
cours
dose
per
patient
oseltamivir
donat
stockpil
plan
dramat
increas
size
stockpil
govern
countri
produc
infl
uenza
vaccin
antivir
agent
purchas
suppli
oseltamivir
stockpil
suffi
cient
treat
combin
popul
ds
fedson
unpub
data
surprisingli
develop
countri
alloc
scarc
resourc
stockpil
signifi
cant
quantiti
oseltamivir
unpredict
infl
uenza
pandem
clearli
limit
suppli
antivir
agent
avail
develop
countri
infect
occur
scarc
effect
pandem
start
spread
infl
uenza
virologist
report
recent
isol
highli
pathogen
infl
uenza
virus
acquir
molecular
characterist
suggest
might
becom
easili
transmiss
among
human
indonesia
physician
report
everyon
infect
clade
infl
uenza
viru
receiv
antivir
treatment
die
tabl
given
extrem
limit
global
suppli
antivir
agent
terrifi
observ
pandem
viru
emerg
level
virul
approach
infl
uenza
viru
indonesia
could
lead
global
popul
collaps
mani
infl
uenza
virologist
doubt
ever
happen
believ
instead
infl
uenza
viru
reemerg
infl
uenza
viru
could
also
caus
next
pandem
chanc
might
right
moreov
health
offi
cial
nation
govern
intern
agenc
estim
expect
pandem
death
extrapol
pandem
offi
cial
seldom
ever
use
phrase
popul
collaps
popul
die
estim
may
also
right
nonetheless
semin
experi
report
webster
campbel
show
genet
reassort
process
gave
rise
pandem
virus
could
give
rise
readili
transmiss
viru
extraordinari
virul
figur
experi
human
experi
infl
uenza
viru
indonesia
suggest
would
prudent
countri
plan
someth
much
wors
occur
current
approach
pandem
plan
countri
involv
small
group
health
offi
cial
infl
uenza
scientist
compani
execut
come
industri
countri
forese
futur
topdown
approach
incap
provid
develop
countri
time
suppli
afford
vaccin
antivir
agent
industri
countri
produc
infl
uenza
vaccin
similar
diffi
culti
least
fi
rst
pandem
wave
indonesian
health
minist
one
understand
littl
prospect
peopl
countri
abl
obtain
vaccin
pandem
virus
precipit
standoff
announc
februari
unless
indonesia
abl
gain
access
suppli
vaccin
pandem
virus
countri
longer
share
infl
uenza
virus
laboratorybas
surveil
system
despit
unorthodox
argument
posit
garner
wide
support
health
minist
mani
develop
countri
recent
indonesia
agre
share
infl
uenza
viru
sequenc
virus
global
initi
share
avian
infl
uenza
data
countri
longer
promptli
report
death
infl
uenza
viru
defi
anc
new
intern
health
regul
unabl
come
solut
impass
identifi
major
issu
challeng
pandem
threat
face
develop
countri
oshitani
et
al
call
better
prepared
plan
improv
system
medic
care
public
health
expand
use
nonpharmaceut
intervent
strengthen
core
capac
season
infl
uenza
surveil
vaccin
recogn
challeng
develop
countri
abl
meet
go
say
prepar
pandem
simpli
strengthen
prepared
within
singl
countri
possibl
pandem
global
issu
pandem
prepared
consid
global
perspect
practic
term
exactli
mean
record
thu
far
indic
truli
intern
effort
prepar
pandem
vaccin
antivir
use
meager
almost
instanc
effort
vastli
outweigh
effort
refl
ect
nation
concern
interest
topdown
approach
ensur
adequ
afford
suppli
vaccin
pandem
virus
antivir
agent
produc
distribut
time
protect
popul
develop
countri
transfer
technolog
vaccin
antivir
agent
product
small
number
develop
countri
proceed
slowli
inevit
fail
meet
need
neighbor
countri
favor
program
consequ
develop
countri
must
consid
altern
bottomup
approach
pandem
control
approach
base
exist
healthcar
worker
institut
use
inexpens
wide
avail
gener
agent
intrins
antivir
activ
modifi
host
respons
mani
infl
uenza
scientist
doubt
approach
work
nonetheless
review
elsewher
sever
retrospect
studi
suggest
outpati
statin
drug
taken
lower
cholesterol
level
prevent
cardiovascular
diseas
reduc
pneumonia
mortal
rate
tabl
investig
agre
observ
studi
must
interpret
caution
promis
result
follow
prospect
clinic
trial
one
trial
alreadi
way
preliminari
report
shown
pneumonia
patient
intens
care
unit
treatment
statin
reduc
hospit
mortal
rate
p
pulmonari
investig
also
believ
peroxisom
proliferatoractiv
receptor
ppar
agonist
fi
brate
glitazon
respect
could
use
treat
acut
lung
injuri
import
experiment
studi
shown
fi
brate
gemfi
brozil
agonist
use
prevent
heart
diseas
reduc
mortal
rate
mice
infect
infl
uenza
viru
statin
ppar
agonist
antiinfl
ammatori
immunomodulatori
activ
consider
molecular
crosstalk
agent
moreov
combin
treatment
safe
patient
cardiovascular
diseas
clinic
benefi
ts
addit
use
either
alon
togeth
treatment
might
similarli
benefi
patient
infl
uenza
pandem
gener
agent
direct
activ
infl
uenza
viru
also
consid
chloroquin
long
use
antimalari
drug
increas
endosom
ph
act
antivir
agent
impair
viru
releas
cytosol
resveratrol
polyphenol
found
red
wine
reduc
infl
uenza
mortal
rate
experiment
infect
mice
catechin
found
green
tea
curcumin
turmer
found
curri
powder
numer
cellsign
effect
suggest
might
benefi
cial
combin
agent
act
host
respons
viru
might
requir
becom
increasingli
diffi
cult
investig
ignor
argument
treat
host
respons
infl
uenza
recent
investig
show
give
neuraminidas
inhibitor
mice
infect
infl
uenza
viru
nearli
effect
treat
mice
antivir
agent
immunomodulatori
agent
mesalazin
agonist
celecoxib
cyclooxygenas
cox
inhibitor
model
target
host
respons
infect
essenti
improv
surviv
rate
time
import
studi
mice
show
intratrach
administr
either
fragment
protein
infl
uenza
viru
inactiv
infl
uenza
viru
caus
sever
acut
lung
injuri
similar
seen
fatal
human
case
infl
uenza
either
pandem
current
subtyp
experiment
model
viru
replic
thu
antivir
agent
would
effect
although
still
lack
direct
evid
one
antiinfl
ammatori
immunomodulatori
agent
alon
would
effect
treat
human
infl
uenza
viru
infect
result
studi
infl
uenza
viru
infect
mice
treat
gemfi
brozil
suggest
agent
might
effect
make
agent
import
mani
current
produc
gener
drug
develop
countri
drug
inexpens
could
produc
abund
could
even
stockpil
made
avail
use
fi
rst
day
pandem
matter
accomplish
year
ahead
adequ
suppli
vaccin
specifi
c
antivir
agent
never
avail
person
develop
countri
fi
rst
pandem
day
type
research
gener
agent
need
pandem
viru
appear
first
experiment
studi
sever
candid
treatment
regimen
must
undertaken
mice
infect
infl
uenza
viru
virus
tabl
agent
use
studi
might
antiinfl
ammatori
immunomodulatori
antivir
properti
might
must
gener
agent
current
produc
develop
countri
admittedli
experiment
studi
mice
limit
identifi
avenu
research
treatment
regimen
shown
effect
mice
test
ferret
later
promis
regimen
test
nonhuman
primat
demonstr
effect
treatment
regimen
anim
infl
uenza
virologist
use
vitro
system
defi
ne
molecular
mechan
respons
protect
activ
howev
agent
broader
effect
host
respons
exampl
although
administ
inhibitor
along
agonist
improv
surviv
rate
time
mice
infect
infl
uenza
viru
anoth
studi
show
select
inhibit
detriment
resolut
acut
lung
injuri
infl
uenza
scientist
focu
research
viru
cellsign
event
associ
viral
pathogenesi
yet
pathophysiolog
effect
sever
infect
involv
entir
host
someth
well
known
research
studi
sepsi
studi
shown
statin
ppar
agonist
stabil
myocardi
microvascular
function
preserv
integr
pulmonari
endotheli
cell
tight
junction
prevent
pulmonari
edema
promot
resolut
acut
infl
ammat
thu
investig
laboratori
clinic
expertis
critic
care
cardiopulmonari
diseas
endocrinolog
metabol
must
recruit
explor
anim
molecular
mechan
underli
broad
treatment
effect
host
howev
undertak
research
investig
must
forget
primari
goal
fi
nd
effect
way
manag
pandem
popul
simpli
explain
precis
term
harm
effect
pandem
viru
infect
individu
studi
way
analysi
undertaken
candid
agent
determin
compani
produc
manufactur
annual
level
product
surg
capac
pattern
distribut
develop
countri
cost
public
market
tabl
special
attent
must
given
compani
follow
good
manufactur
practic
minim
risk
agent
might
counterfeit
anim
studi
defi
ned
promis
regimen
intern
process
must
set
develop
logist
fi
nanc
produc
distribut
agent
feasibl
clinic
trial
promis
treatment
regimen
might
undertaken
patient
sever
season
infl
uenza
instanc
clinician
might
choos
treat
patient
infect
infl
uenza
viru
compassion
basi
howev
none
limit
studi
guarante
promis
treatment
prepandem
period
effect
true
pandem
viru
thu
care
plan
must
made
prepandem
period
enabl
investig
conduct
random
control
trial
promis
gener
regimen
earli
week
new
pandem
casefat
rate
similar
infl
uenza
viru
trial
need
larg
tabl
within
day
investig
abl
recruit
suffi
cient
number
patient
satisfi
statist
requir
plan
clinic
trial
prepandem
period
must
start
identifi
clinic
investig
conduct
trial
institut
sponsor
work
suppli
agent
test
must
set
asid
studi
protocol
written
ethic
approv
obtain
mechan
rapid
regulatori
approv
must
develop
enabl
trial
conduct
wherev
pandem
viru
fi
rst
emerg
fi
nanc
mechan
must
establish
enabl
immedi
access
fund
necessari
support
trial
final
internetbas
commun
strategi
must
devis
ensur
prompt
dissemin
studi
result
physician
health
offi
cial
worldwid
none
research
gener
agent
possibl
without
intern
coordin
thu
far
topdown
approach
character
vaccin
antivir
research
develop
lack
intern
system
coordin
manag
ensur
rapid
progress
likewis
noth
done
ensur
worldwid
product
distribut
vaccin
antivir
agent
develop
similar
approach
must
allow
govern
research
agenda
gener
agent
experi
sever
acut
respiratori
syndrom
sar
show
us
could
much
better
sar
fi
rst
came
intern
attent
quickli
establish
virtual
network
experienc
virologist
clinician
epidemiologist
share
experi
fi
nding
secur
websit
daili
teleconfer
investig
soon
identifi
ed
sequenc
sar
coronaviru
defi
ned
clinic
fea
tabl
research
agenda
establish
whether
gener
agent
could
use
treatment
prophylaxi
pandem
caus
subtyp
influenza
viru
test
candid
treatment
regimen
mice
ferret
nonhuman
primat
identifi
specif
gener
agent
might
effect
manag
pandem
studi
promis
gener
treatment
cell
cultur
anim
defin
molecular
mechan
explain
benefici
effect
influenza
viru
influenza
virus
conduct
global
analysi
identifi
develop
countri
gener
agent
produc
determin
quantiti
produc
surg
capac
pattern
distribut
cost
public
program
establish
intern
process
coordin
manag
stockpil
gener
agent
andor
distribut
pandem
viru
emerg
plan
conduct
random
control
trial
promis
gener
treatment
immedi
emerg
new
pandem
viru
ture
diseas
establish
practic
measur
clinic
manag
epidemiolog
control
surprisingli
set
similar
system
coordin
research
develop
vaccin
pandem
virus
antivir
agent
despit
far
greater
threat
global
health
inher
infl
uenza
pandem
given
escal
pressur
develop
countri
ill
afford
adopt
slow
approach
establish
scientifi
c
basi
use
inexpens
wide
avail
gener
agent
pandem
control
oshitani
et
al
correctli
emphas
prepar
next
pandem
requir
global
perspect
necessarili
mean
measur
use
confront
pandem
develop
countri
must
suppli
intern
organ
topdown
process
intern
process
sure
requir
distribut
vaccin
antivir
agent
experi
indic
process
slow
cumbersom
suppli
agent
remain
scarc
nonetheless
develop
countri
need
abund
suppli
effect
agent
abund
guarante
agent
gener
inexpens
produc
develop
countri
soon
know
whether
gener
agent
could
use
confront
next
infl
uenza
pandem
yet
develop
countri
lack
realist
altern
reason
leader
must
convinc
scientist
intern
organ
includ
urgent
need
research
determin
whether
inexpens
agent
could
mitig
effect
pandem
otherwis
develop
industri
countri
alik
could
face
unpreced
global
health
crisi
